605929

Primrose Candy Co. — FEI 1412287

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 19, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chicago, IL (United States)

Citations

IDCFRDescription
108621 CFR 211.22(b)Adequate lab facilities not available
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
117721 CFR 211.63Equipment Design, Size and Location
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
144821 CFR 211.111Establishment of time limitations
145021 CFR 211.113(a)Procedures for non-sterile drug products
145421 CFR 211.115(a)Reprocessing procedures not written or followed
149621 CFR 211.122(a)Sampling/testing of labeling/packaging materials
155021 CFR 211.125(f)Procedures Written and Followed
155221 CFR 110.35(a)Buildings/sanitary
189121 CFR 211.165(f)Failing drug products not rejected
191421 CFR 211.166(a)Lack of written stability program
200321 CFR 211.184(c)Individual inventory record
201221 CFR 211.188(b)Batch production and Batch Control Record Requirements
202621 CFR 211.192Quality control unit review of records
220521 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
241921 CFR 211.198(a)Complaint Handling Procedure
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360321 CFR 211.160(b)Scientifically sound laboratory controls
361021 CFR 211.160(b)(3)Drug product sample
430321 CFR 211.67(b)Written procedures fail to include
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
433021 CFR 211.130(e)Packaging line inspection documentation
438021 CFR 211.198(b)(3)Determination not to conduct investigation of complaint
457621 CFR 211.192No written record of investigation